Company research
SomaLogic, Inc.
CIK 1837412Updated Sep 24, 2026
Securities
Name history
CM Life Sciences II Inc. · through Sep 1, 2021
CMII price & chart
Historical security
This listing closed Sep 2, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 647,374,000Source | 706,102,000Source | 242,290,000Source |
| Property, Plant and Equipment, NetUSD | 19,564,000Source | 9,557,000Source | 3,913,000Source |
| GoodwillUSD | 10,399,000Source | — | — |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 421,830,000Source | 439,488,000Source | 164,944,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 17,006,000Source | 17,074,000Source | 17,449,000Source |
| Inventory, NetUSD | 13,897,000Source | 11,213,000Source | 7,020,000Source |
| Assets, CurrentUSD | 581,701,000Source | 691,552,000Source | 231,975,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 9,873,000Source | 5,097,000Source | 1,158,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,900,000Source | — | — |
| Other Assets, NoncurrentUSD | 5,083,000Source | 908,000Source | 378,000Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 84,816,000Source | 94,078,000Source | 56,373,000Source |
| Stockholders’ equity: | |||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 19,000Source | 18,000Source | 11,000Source |
| Additional Paid in CapitalUSD | 1,171,122,000Source | 1,110,991,000Source | 597,274,000Source |
| Retained Earnings (Accumulated Deficit)USD | -608,070,000Source | -498,913,000Source | -411,366,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -513,000Source | -72,000Source | -2,000Source |
| Stockholders' Equity Attributable to ParentUSD | 562,558,000Source | 612,024,000Source | 185,917,000Source |
| Liabilities and EquityUSD | 647,374,000Source | 706,102,000Source | 242,290,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 43,332,000Source | 29,285,000Source | 17,797,000Source |
| Operating Lease, Liability, CurrentUSD | 2,477,000Source | — | — |
| Accounts Payable, CurrentUSD | 16,794,000Source | 15,089,000Source | 7,064,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,063,000Source | — | — |
| Deferred Income Tax Liabilities, NetUSD | — | 0Source | 0Source |
| Other Liabilities, NoncurrentUSD | 5,524,000Source | 363,000Source | 909,000Source |
| Additional Financial Items | |||
| Accounts Receivable, after Allowance for Credit LossUSD | 26,290,000Source | — | — |
| Deferred Tax Liabilities, NetUSD | 585,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 0Source | — |
| Long-term Debt, Current MaturitiesUSD | — | 0Source | 2,423,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 0Source | 32,326,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, Depletion and AmortizationUSD | 4,571,000Source | 2,569,000Source | 2,823,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 43,609,000Source | 28,415,000Source | 15,172,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | 9,366,000Source | -383,000Source | 13,306,000Source |
| Increase (Decrease) in InventoriesUSD | 3,732,000Source | 2,957,000Source | -483,000Source |
| Increase (Decrease) in Accounts PayableUSD | 2,340,000Source | 6,460,000Source | 4,025,000Source |
| Deferred Income Tax Expense (Benefit)USD | -806,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -100,669,000Source | -36,972,000Source | -28,338,000Source |
| Cash flows from investing activities: | |||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 13,256,000Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 82,542,000Source | -185,431,000Source | -9,535,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 5,215,000Source | 6,729,000Source | 1,157,000Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 5,185,000Source | 497,491,000Source | 188,766,000Source |
| Repayments of Long-term DebtUSD | 0Source | 36,512,000Source | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -12,985,000Source | 275,074,000Source | 150,884,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 427,283,000Source | 440,268,000Source | 165,194,000Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 0Source | 1,627,000Source | 3,730,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -43,000Source | -14,000Source | -9,000Source |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 43,609,000Source | 28,415,000Source | 15,172,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 0Source | 258,000Source | 1,670,000Source |
| Capitalized Computer Software, AmortizationUSD | 2,700,000Source | 800,000Source | 500,000Source |
| DepreciationUSD | 1,900,000Source | 1,800,000Source | 2,300,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | 0Source | -98,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | -4,323,000Source | -551,000Source |
| GoodwillUSD | 10,399,000Source | — | — |
| Income Tax Expense (Benefit)USD | -717,000Source | 38,000Source | 23,000Source |
| Inventory Write-downUSD | 490,000Source | 703,000Source | 102,000Source |
| Net Income (Loss) Attributable to ParentUSD | -109,157,000Source | -87,547,000Source | -53,015,000Source |
| Nonoperating Income (Expense)USD | 65,887,000Source | -14,243,000Source | -18,659,000Source |
| Operating ExpensesUSD | 273,427,000Source | 154,930,000Source | 90,245,000Source |
| Proceeds from Stock Options ExercisedUSD | — | 3,947,000Source | 1,105,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Total RevenueUSD | 97,666,000Source | 81,626,000Source | 55,889,000Source |
| Selling, General and Administrative ExpenseUSD | 156,619,000Source | 77,971,000Source | 36,882,000Source |
| Operating Income (Loss)USD | -175,761,000Source | -73,304,000Source | -34,356,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -109,874,000Source | — | — |
| Income Tax Expense (Benefit)USD | -717,000Source | 38,000Source | 23,000Source |
| Net Income (Loss) Attributable to ParentUSD | -109,157,000Source | -87,547,000Source | -53,015,000Source |
| Earnings Per Share, BasicUSD per share | -0.59Source | -0.64Source | -0.81Source |
| Earnings Per Share, DilutedUSD per share | -0.59Source | -0.64Source | -0.81Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 183,991,643Source | 137,157,283Source | 65,161,358Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 183,991,643Source | 137,157,283Source | 65,161,358Source |
| Additional Financial Items | |||
| Business Combination, Acquisition Related CostsUSD | — | 31,511,000Source | — |
| Capitalized Computer Software, AmortizationUSD | 2,700,000Source | 800,000Source | 500,000Source |
| Interest and Other IncomeUSD | 8,049,000Source | 225,000Source | 230,000Source |
| Interest ExpenseUSD | 0Source | 1,324,000Source | 18,338,000Source |
| Nonoperating Income (Expense)USD | 65,887,000Source | -14,243,000Source | -18,659,000Source |
| Operating ExpensesUSD | 273,427,000Source | 154,930,000Source | 90,245,000Source |
| Research and Development ExpenseUSD | 73,444,000Source | 43,496,000Source | 30,749,000Source |